The effects of thymostimulin on immunological function in patients with head and neck cancer

Clinical Otolaryngology and Allied Sciences

Volumn 21, Issue 5, 1996, Pages 455-462

  Kerrebijn, J D F ^a,b   Simons, P J ^b   Tas, M ^c   Knegt, P P ^a   Van De Brekel, M W M ^e   Delaere, P ^f   Tan, I B ^g   Drexhage, H A ^b   Balm, A J M ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Dept Otolaryngol Hd Neck Surg ^*  (Belgium)

^g MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

Dendritic cells; Head and neck carcinoma; Immunotherapy; Monocytes; p15E; Thymostimulin

Indexed keywords

PLACEBO; THYMOSTIMULIN;

ARTICLE; CELLULAR IMMUNITY; CHEMOTAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE FUNCTION TEST; INTRAMUSCULAR DRUG ADMINISTRATION; MONOCYTE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030003336     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.1996.00850.x     Document Type: Article

References (26)

1. BALM A.J.M., DREXHAGE H.A., VON BLOMBERG B.M.E. & SNOW G.B. (1982) Mononuclear phagocyte function in head and neck cancer: NBT-dye reduction, maturation and migration of peripheral blood monocytes. Laryngoscope 92, 810-814
2. BALM A.J.M., VON BLOMBERG-VAN DE FLIER B.M.E., DREXHAGE H.A., DE HAAN-MEULMAN M. & SNOW G.B. (1984) Mononuclear phagocyte function in head and neck cancer: depression of murine macrophage accumulation by low molecular weight factors derived from head and neck carcinomas. Laryngoscope 94, 223-227
3. BALM A.J.M., DREXHAGE H.A., VON BLOMBERG M.E. et al. (1984) Mononuclear phagocyte function in head and neck cancer. Chemotactic responsiveness of blood monocytes in correlation between histologie grade of the tumor and infiltration of these cells into the tumor area. Cancer 54, 1010-1015
4. GÜNGÖR A., YETGIN S. & SÖZERI B. (1993) Defective monocyte chemotaxis in patients with epidermoid tumors of the head and neck. Eur. Arch. Otorhinolaryngol. 250, 289-291
5. TAN I.B., DREXHAGE H.A., SCHEPER R.J. et al. (1986) Defective monocyte chemotaxis in patients with head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 112, 541-544
6. TAN I.B., DREXHAGE H.A., SCHEPER R.J. et al. (1986) Immunosuppressive retroviral P15E-related factors in head and neck carcinomas. Arch. Otolaryngol. Head Neck Surg. 112, 942-945
7. TAN I.B. (1986) Retroviral P15E-related factors in head and neck cancer. Thesis, Vonk/Zeist
8. TAS M.P., SIMONS P.J., BALM A.J.M. & DREXHAGE H.A. (1993) Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones. Cancer Immunol. Immunother. 36, 108-114
9. CIANCIOLO G.J., COPELAND T.D., OROSZLAN S. & SNIJDERMAN R. (1985) Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230, 453-455
10. SIMONS P.J., OOSTENDORP R.A.J., TAS M.P.R. & DREXHAGE H.A. (1994) Comparison of retroviral p15E-related factors and interferon a in head and neck cancer. Cancer Immunol. Immunother. 38, 178-184
11. SCHEEREN R.A. (1992) Chronic upper airway infections. The role of p15E-like proteins and defect in cell-mediated immunity. Thesis, Free University, Amsterdam
12. TAS M., DE HAAN-MEULMAN M., KABEL P.J. & DREXHAGE H.A. (1991) Defects in monocyte polarization and dendritic cell clustering in patients with Graves' disease. A putative role for a nonspecific immunoregulatory factor related to p15E. Clin. Endocrinol. 34, 441-448
13. KERREBIJN J.D., SIMONS P.J., TAS M., BALM A.J.M. & DREXHAGE H.A. (1995) In-vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients. Eur. Arch. Otorhinolarynaol. 252, 409-416
14. KERREBUN J.D., SIMONS P.J., BALM A.J.M. et al. (1996) Thymostimulin (TP1) enhances T-cell infiltration into head and neck squamous cell carcinoma. Head Neck Surg. 18, 335-342
15. TAS M., LEEZENBERG A. & DREXHAGE H.A. (1990) Beneficial effects of the thymic hormone preparation thymostimulin in patients with defects in cell-mediated immunity and chronic purulent rhinosinusitis. A double-blind cross-over trial on improvements in monocyte polarization and clinical effects. Clin. Exp. Immunol. 80, 304-313
16. BERNENGO M.G., FRA P., LISA F., MEREGALLI M. & ZINA G. (1983) Thymostimulin therapy in melanoma patients: correlation of immunologic effects with clinical course. Clin. Immunol. Immunopathol. 28, 311-324
17. AIUTI F., SIRIANNI M.C., FIORILLI M. et al. (1984) A placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient host: results after a 1-year follow-up. Clin. Immunol. Immunopathol. 30, 11-18
18. BERGESI G. & FALCHETTI R. (1977) Chemical characterization and biological activity of a new thymic extract. Folia Allergol. Immunol. Clin. 21, 204-208
19. BERGESI G., FALCHETTI R., ESHKOL A. et al. (1977) Pharmacological and biological properties of a calf thymus extract (TP1). Drugs Exp. Clin. Res. 3, 39-47
20. KABEL P.J., DE HAAN-MEULMAN M., VOORBIJ H.A.M. et al. (1989) Accessory cells with a morphology and marker patterns of dendritic cells can be obtained from elutriator-purified blood monocyte fractions. An enhancing effect of metrizamide in this differentiation. Immunobiol. 179, 395-411
21. MOOIJ P., SIMONS P.J., DE HAAN-MEULMAN M., DE WIT H.J. & DREXHAGE H.A. (1994) Effect of thyroid hormones and other iodinated compounds on the transition of monocytes into veiled dendritic cells: role of granulocyte-macrophage colony-stimulating factor, tumour-necrosis factor-α and interleukin-6. J. Endocrinol. 140, 503-508
22. VAN DONGEN J.J.M., ADRIAANSEN H.J. & HOOIJKAAS H. (1987) Immunological marker analysis of cells in the various hemopoetic differentiation stages and their malignant counterparts. In Application of Monoclonal Antibodies in Tumor Pathology (Ruiter D.J., Fleuren G.J. & Warnaar S.O. eds), pp. 87-116, M. Nijhoff, Dordrecht
23. TAS M., LAARMAN D., DE HAAN-MEULMAN M. et al. (1993) Retroviral p15E-related serum factors and recurrence of head and neck cancer. Clin. Otolaryngol. 18, 324-327
24. GARRAUD O., FAUCHER A. & LEGRAND E. (1988) Impairment of monocyte functions in advanced head and neck cancer. Immunol. Lett. 18, 213-218
25. WALTER R.J. & DANIELSON J.R. (1987) Characterization of formylpeptide chemoattractant binding on eutrophils and monocytes from patients with head and neck cancer. JNCI 78, 61-66
26. CIANCIOLO G.J. (1986) Antiinflammatory proteins associated with human and murine neoplasms. Biochimica et Biophysica Acta 865, 69-82